Literature DB >> 26458819

Diagnosis and Treatment of Anxiety in the Aging Woman.

Andrew M Siegel1,2, Sarah B Mathews3,4.   

Abstract

The peri- and postmenopausal periods represent a window of vulnerability for emergence of anxiety symptoms and disorders in the life cycle of adult women. Compared to depression, anxiety symptoms and disorders remain largely unexplored during this phase of a woman's life, despite the significant impact on quality of life if not diagnosed and treated. Here, we review the literature to present our current understanding of the epidemiology, causal factors, diagnosis, and treatment of anxiety in the aging woman.

Entities:  

Keywords:  Anxiety and aging; Diagnosis; Estradiol; HPA axis; Medication; Menopause; Perimenopause; Postmenopause; Psychotherapy; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26458819     DOI: 10.1007/s11920-015-0636-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  56 in total

1.  Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition.

Authors:  Pauline M Maki; Ellen W Freeman; Gail A Greendale; Victor W Henderson; Paul A Newhouse; Peter J Schmidt; Nelda F Scott; Carol A Shively; Claudio N Soares
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

2.  Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women.

Authors:  K A Matthews; R R Wing; L H Kuller; E N Meilahn; S F Kelsey; E J Costello; A W Caggiula
Journal:  J Consult Clin Psychol       Date:  1990-06

3.  Mindfulness-based stress reduction, mindfulness-based cognitive therapy, and Zen meditation for depression, anxiety, pain, and psychological distress.

Authors:  William R Marchand
Journal:  J Psychiatr Pract       Date:  2012-07       Impact factor: 1.325

Review 4.  Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.

Authors:  Jennifer L Gordon; Susan S Girdler; Samantha E Meltzer-Brody; Catherine S Stika; Rebecca C Thurston; Crystal T Clark; Beth A Prairie; Eydie Moses-Kolko; Hadine Joffe; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2015-01-13       Impact factor: 18.112

5.  Incidence and risk factors for depression and anxiety disorders: results from a 34-year longitudinal Swedish cohort study.

Authors:  G Samuelsson; C McCamish-Svensson; B Hagberg; G Sundström; Ove Dehlin
Journal:  Aging Ment Health       Date:  2005-11       Impact factor: 3.658

6.  Symptom interference with work and relationships during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

7.  Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors.

Authors:  M Egan; Y Moride; C Wolfson; J Monette
Journal:  J Am Geriatr Soc       Date:  2000-07       Impact factor: 5.562

8.  [Benzodiazepine addiction and symptoms of anxiety and depression in elderly subjects].

Authors:  L Fernandez; C Cassagne-Pinel
Journal:  Encephale       Date:  2001 Sep-Oct       Impact factor: 1.291

9.  Symptoms in the menopausal transition: hormone and behavioral correlates.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia; Shiv Kapoor
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

Review 10.  Risk factors for anxiety and depression in the elderly: a review.

Authors:  Dagmar Vink; Marja J Aartsen; Robert A Schoevers
Journal:  J Affect Disord       Date:  2007-08-17       Impact factor: 4.839

View more
  4 in total

Review 1.  Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population.

Authors:  Charlene Faye; Josephine C Mcgowan; Christine A Denny; Denis J David
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363

2.  Progesterone increased β-endorphin innervation of the locus coeruleus, but ovarian steroids had no effect on noradrenergic neurodegeneration.

Authors:  Fernanda B Lima; Cristiane M Leite; Cynthia L Bethea; Janete A Anselmo-Franci
Journal:  Brain Res       Date:  2017-03-08       Impact factor: 3.252

3.  Anxiety Disorders Among Women: A Female Lifespan Approach.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Focus (Am Psychiatr Publ)       Date:  2017-04-10

4.  PAUSE: A Patient-Centric Tool to Support Patient-Provider Engagement on Menopause.

Authors:  Rebecca Ashkenazy; Mary Elizabeth Peterson
Journal:  Clin Med Insights Womens Health       Date:  2018-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.